Drug Shortage Report for ENGERIX-B
Report ID | 105174 |
Drug Identification Number | 02487039 |
Brand name | ENGERIX-B |
Common or Proper name | Hepatitis B vaccine (recombinant) |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 20MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's (prefilled syringe / seringue préremplie) |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-02-03 |
Estimated end date | 2020-03-27 |
Actual end date | 2020-03-24 |
Shortage status | Resolved |
Updated date | 2020-03-25 |
Company comments | Inventory on allocation to support demand in private market. Supply available for public programs. |
Health Canada comments | |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.